Alpha-lipoic Acid Adjunctive Therapy in Schizophrenia

NCT03788759 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia
Oxidative Stress

Interventions

DRUG: Alpha-lipoic acid
DRUG: Placebo Oral Tablet

Sponsor

Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara

Collaborators

[object Object]